Physician profile
Eric Sommer
NPI 1659447092
$7,246.47
in general payments reported to CMS, 2019-2025
23 companies · $312 in 2025
The $312 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,032 · 2020: $920 · 2021: $1,311 · 2022: $1,018 · 2023: $1,180 · 2024: $474 · 2025: $312.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,965.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,964.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $2,064.54 | 2019-2024 | Harmonic, Echelon Flex, Stratafix |
| Intuitive Surgical, INC. | $1,040.42 | 2019-2023 | |
| Medtronic, INC. | $827.02 | 2021-2024 | Signia, Ligasure, Endo Gia Ultra |
| Novo Nordisk INC | $754.31 | 2019-2025 | Wegovy |
| W. L. Gore & Associates, INC. | $640.57 | 2019-2023 | Gore Seamguard Bioabsorbable Staple Line Reinforce |
| Covidien Lp | $461.28 | 2019 | |
| Redhill Biopharma INC. | $260.31 | 2020-2022 | |
| Senseonics, Incorporated | $240.00 | 2020 | |
| Endo Pharmaceuticals INC. | $226.90 | 2019-2024 | Nascobal |
| Currax Pharmaceuticals LLC | $168.82 | 2021-2025 | Contrave |
| Lilly USA, LLC | $153.81 | 2024-2025 | Mounjaro, Zepbound |
| Teleflex LLC | $63.85 | 2021-2024 | Titan Sgs Standard Gastric Stapler, Titan Sgs |
| Hologic Sales and Service, LLC | $48.71 | 2024 | Coolseal Generator |
| Conmed Corporation | $48.03 | 2024 | Airseal |
| Innovation Technologies INC | $40.74 | 2023 | Irrisept |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cumberland Pharmaceuticals, INC. | $37.68 | 2023 | Caldolor |
| Apollo Endosurgery US INC | $35.78 | 2019-2021 | |
| Lsi Solutions INC | $28.70 | 2019 | |
| Intra-Sana Laboratories | $25.09 | 2021 | |
| Heron Therapeutics, INC. | $24.42 | 2023 | Aponvie |
| Acell, INC. | $22.01 | 2020 | |
| Shire North American Group INC | $16.76 | 2019 | |
| Reshape Lifesciences INC. | $16.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Sommer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.